Withdrawn: Experimental Study on NRF2 Mediated by Chinese Medicine Tangzhiqing to Reduce Autophagy-dependent Ferroptosis and Alleviate Neuron Damage in HT22 Mice with Diabetes-related Cognitive Disorder

IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Endocrine, metabolic & immune disorders drug targets Pub Date : 2023-06-22 DOI:10.2174/1871530323666230622151649
Lingyan Qiu, Kai Chen, Xu Wang, Yun Zhao
{"title":"Withdrawn: Experimental Study on NRF2 Mediated by Chinese Medicine Tangzhiqing to Reduce Autophagy-dependent Ferroptosis and Alleviate Neuron Damage in HT22 Mice with Diabetes-related Cognitive Disorder","authors":"Lingyan Qiu,&nbsp;Kai Chen,&nbsp;Xu Wang,&nbsp;Yun Zhao","doi":"10.2174/1871530323666230622151649","DOIUrl":null,"url":null,"abstract":"<p><p>The article has been withdrawn at the request of the authors of the journal Endocrine, Metabolic & Immune Disorders-Drug Targets.</p><p><p>Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.</p><p><p>The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.</p><p><strong>Bentham science disclaimer: </strong>It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultane-ously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine, metabolic & immune disorders drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1871530323666230622151649","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

The article has been withdrawn at the request of the authors of the journal Endocrine, Metabolic & Immune Disorders-Drug Targets.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.

Bentham science disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultane-ously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
停药:中药唐志清介导的NRF2降低糖尿病相关认知障碍HT22小鼠自噬依赖性铁下垂和减轻神经元损伤的实验研究
应《内分泌、代谢和免疫疾病药物靶点》杂志作者的要求,该文章已被撤回。Bentham Science对由此造成的不便向该杂志读者道歉。Bentham关于文章撤回的编辑政策可以在https://benthamscience.com/editorial-policies-main.php.Bentham科学免责声明:发表的一个条件是,提交给本杂志的手稿没有发表,也不会同时提交或在其他地方发表。此外,必须报告在其他地方发布的任何数据、插图、结构或表格,并获得复制的版权许可。严禁抄袭,通过提交文章发表,作者同意,如果发现抄袭或捏造信息,出版商有权对作者采取适当行动。通过提交手稿,作者同意,如果文章被接受发表,他们文章的版权将转移给出版商。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrine, metabolic & immune disorders drug targets
Endocrine, metabolic & immune disorders drug targets ENDOCRINOLOGY & METABOLISMIMMUNOLOGY-IMMUNOLOGY
CiteScore
4.60
自引率
5.30%
发文量
217
期刊介绍: Aims & Scope This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.
期刊最新文献
WITHDRAWN: Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the basis of Differences in Ethnicity and Curcumin as a Possible Treatment Single-Cell RNA Sequencing Reveals Transcriptional Signatures and Cell-Cell Communication in Diabetic Retinopathy Current Developments in the Prevention and Improvement of Intestinal Disorders: A Mini-Review Clinical Presentation, Diagnosis, and Management of Hyperinsulinemic Hypoglycemia in Adults: A Single-center Experience Diabulimia and Type 1 Diabetes: An Unknown and Emerging Problem
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1